Free Fatty Acid Effects In Type 2 Diabetes
NCT07677995 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-07-01
Summary
Omega-3 fatty acids are natural fats found in foods such as oily fish and flaxseed. Omega-3 fatty acids have been found to have positive effects on cardiovascular health, but there is less evidence on if they can help manage blood glucose in individuals with both cardiovascular disease and type 2 diabetes.
This study will investigate whether the beneficial effects found in omega-3 fatty acids such as lowered blood glucose and reduced inflammation - both of which are important for managing type 2 diabetes and cardiovascular disease, can be beneficial for individuals with type 2 diabetes. As omega-3 fatty acids are already found naturally in food, and are already available as supplements, they could be a safe option to help manage these diseases.
The aim of this study is to investigate if omega-3 fatty acids can slow down the progression of type 2 diabetes and reduce the risk of cardiovascular disease in individuals with type 2 diabetes.
Conditions
- Type 2 Diabetes
- Cardiovascular Disease
- Omega-3 Fatty Acids
Interventions
- DIETARY_SUPPLEMENT
-
Omega-3 Fatty Acids
1500mg/day for 28 days
- DRUG
-
Semaglutide 0.25 mg
0.25mg weekly for four weeks
- DIETARY_SUPPLEMENT
-
Placebo
Receive placebo
Sponsors & Collaborators
-
University of Ulster
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-31
- Primary Completion
- 2026-12-31
- Completion
- 2027-02-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)
NCT03120299 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of N-3 Polyunsaturated Fatty Acids On Chylomicron Secretion And Expression Of Genes That Regulate Intestinal Lipid Metabolism In Men With Type 2 Diabetes
NCT01449773 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids and Insulin Sensitivity
NCT01686568 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274 ·Status: COMPLETED ·Phase: NA
-
Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance
NCT01215903 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Fish Oil on Insulin Sensitivity
NCT01241474 ·Status: COMPLETED ·Phase: NA
-
"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus."
NCT07352618 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients
NCT00758927 ·Status: UNKNOWN ·Phase: PHASE4
-
Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus
NCT06061510 ·Status: COMPLETED ·Phase: NA
-
Effects of Fish Oils on Inflammation and Insulin Resistance
NCT00579436 ·Status: COMPLETED ·Phase: NA
-
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids
NCT04485871 ·Status: RECRUITING ·Phase: NA
-
Vitamin D and Omega-3 Inhibit Metabolic Syndrome
NCT01326442 ·Status: COMPLETED ·Phase: PHASE3
-
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
NCT00504309 ·Status: COMPLETED ·Phase: NA
-
Effects of Dietary Polyphenols and ω-3 Fatty Acids on Cardiovascular Risk Factors in High Risk Subjects
NCT01154478 ·Status: COMPLETED ·Phase: NA
-
Intervention With Omega Fatty Acids in High-risk Patients
NCT02647333 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
NCT01034540 ·Status: COMPLETED ·Phase: NA
-
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414 ·Status: COMPLETED ·Phase: NA
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Omega-3 Fatty Acids Supplementation Improves Early-stage Diabetic Nephropathy and Subclinical Atherosclerosis in Pediatric Patients With Type 1 Diabetes
NCT05980026 ·Status: COMPLETED ·Phase: NA
-
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
NCT00323414 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients
NCT01857167 ·Status: COMPLETED ·Phase: NA
-
Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women
NCT00371982 ·Status: TERMINATED ·Phase: NA
-
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy
NCT05169060 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2